L Yang, X Qiu, Q Zhao, H Qiu, Y Cheng… - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Ibrutinib, one Food and Drug Administration-approved, orally available, small-
molecule Bruton tyrosine kinase (BTK) inhibitor, is an effective targeted therapy for patients …